Armel Stockis - Concepedia

Author

Armel Stockis

UCB Pharma (Belgium)ORCID

Also Known As

A STOCKIS, A Stockis, A. Stockis, Armel Stockis, C Otoul, Janet Wade

115

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

UCB Pharma (Belgium)UCB Pharma (United States)Chiesi (France)Ziekenhuisnetwerk Antwerpen Stuivenberg

About

Armel Stockis is an author at UCB Pharma (Belgium) specializing in pharmacotherapy, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	34	1.3K
2	Health Sciences	2	2	48
3	Biochemistry	2	2	35
4	Natural Sciences	1	1	16
5	Anesthesia	1	1	138

Armel Stockis

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Levetiracetam Intravenous Infusion: A Randomized, Placebo‐controlled Safety and Pharmacokinetic Study Steven Ramael, Agnès Daoust, Christian Otoul, Epilepsia	2006	191
Nitazoxanide: pharmacokinetics and metabolism in man J. Broekhuysen, Armel Stockis, R. Lins, International Journal of Clinical Pharmacology and Therapeutics	2000	172
Brivaracetam, a selective high‐affinity synaptic vesicle protein 2A (<scp>SV</scp>2A) ligand with preclinical evidence of high brain permeability and fast onset of action Jean‐Marie Nicolas, Jonas Hannestad, Daniel Holden, Epilepsia	2015	159
The pharmacokinetics of oxybutynin in man J. Douchamps, F. Derenne, Armel Stockis, European Journal of Clinical Pharmacology Voiding DysfunctionMedicinePharmacotherapyAnesthesiaPharmacology	1988	138
The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after single increasing oral doses in healthy males Maria Laura Sargentini‐Maier, Paul Rolan, John Connell, British Journal of Clinical Pharmacology	2007	135
The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after multiple increasing oral doses in healthy men Paul Rolan, Maria Laura Sargentini‐Maier, Etienne Pigeolet, British Journal of Clinical Pharmacology PharmacotherapyAdverse Event ProfileExperimental PharmacologyPharmacodynamic ModelingPre-clinical Pharmacology	2008	119
Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects Steven Ramael, Florimond De Smedt, Nathalie Toublanc, Clinical Therapeutics Single-dose BioavailabilityTherapeutic Drug MonitoringHealthy SubjectsLevetiracetam Intravenous InfusionPharmacology	2006	118
Assessment of a white matter reference region for <sup>11</sup>C-UCB-J PET quantification Samantha Rossano, Takuya Toyonaga, Sjoerd J. Finnema, Journal of Cerebral Blood Flow & Metabolism	2019	117
Pharmacokinetics and Metabolism of 14C-Brivaracetam, a Novel SV2A Ligand, in Healthy Subjects Maria Laura Sargentini‐Maier, Pascal Espié, Alain Coquette, Drug Metabolism and Disposition	2007	112
Evaluation of brivaracetam, a novel SV2A ligand, in the photosensitivity model Dorothée Kasteleijn‐Nolst Trenité, Pierre Genton, D. Parain, Neurology	2007	109

Page 1